Stay updated on Oncolytics Biotech Press Releases

Sign up to get notified when there's something new on the Oncolytics Biotech Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Oncolytics Biotech Press Releases page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a press release announcing FDA Fast Track designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer (Feb 4, 2026). Removed a press release about aligning FDA pivotal study design for Pelareorep in First-Line Pancreatic Cancer (Nov 19, 2025).
    Difference
    1%
    Check dated 2026-02-11T09:19:20.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Added two January 2026 press releases to the News page (Jan 15 and Jan 14). Removed two older items (Nov 4 and Oct 28, 2025).
    Difference
    6%
    Check dated 2026-01-21T04:30:43.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Four new press releases were added to the News page dated January 7–12, 2026, covering updated clinical data for pelareorep plus atezolizumab, the proposed change of jurisdiction to Nevada, IP strategy updates, and the expansion of the GI tumor Scientific Advisory Board. Older 2025 posts were removed from the listing.
    Difference
    6%
    Check dated 2026-01-14T02:54:58.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Footer copyright notice on the News page updated from 2025 to 2026; no impact on navigation or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-07T00:41:51.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    A new press release about promising efficacy data for Pelareorep in KRAS-mutant metastatic colorectal cancer was added on December 16, 2025. An older press release detailing updated clinical safety data across multiple gastrointestinal tumors was removed on September 2, 2025.
    Difference
    1%
    Check dated 2025-12-23T17:12:50.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Added a new press release: rescheduling of the special meeting to change incorporation jurisdiction to Nevada (Dec 9, 2025). Removed an outdated entry: 'Oncolytics Biotech® Announces Upcoming Investor Conferences in September' (Aug 28, 2025).
    Difference
    1%
    Check dated 2025-12-16T06:39:03.000Z thumbnail image

Stay in the know with updates to Oncolytics Biotech Press Releases

Enter your email address, and we'll notify you when there's something new on the Oncolytics Biotech Press Releases page.